Suchergebnisse - "Vályi-Nagy, István"

PubPharm (6)

1

Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers

enthalten in: Vaccines | 2023

von Matula, Z. | Bekő, G. | Király, V. | +5

2

Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy

enthalten in: Vaccines | 2022

von Matula, Z. | Gönczi, M. | Bekő, G. | +4

3

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

CommentIn: Geroscience. 2022 Feb;44(1):57-61. - PMID 34935099

4

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

5

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: GeroScience | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

6

Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans

enthalten in: Age | 2021

von Vályi-Nagy, I. | Matula, Z. | Gönczi, M. | +5

1
[1]